{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T11:14:31Z","timestamp":1791630871589,"version":"4.3.4"},"reference-count":68,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2010,4,1]],"date-time":"2010-04-01T00:00:00Z","timestamp":1270080000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2010,4]]},"DOI":"10.1016\/j.ygyno.2009.12.012","type":"journal-article","created":{"date-parts":[[2010,1,7]],"date-time":"2010-01-07T09:16:33Z","timestamp":1262855793000},"page":"88-95","source":"Crossref","is-referenced-by-count":26,"title":["Lysophosphatidic acid (LPA) effects on endometrial carcinoma in vitro proliferation, invasion, and matrix metalloproteinase activity"],"prefix":"10.1016","volume":"117","author":[{"given":"Feng-qiang","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edgardo V.","family":"Ariztia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leslie R.","family":"Boyd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faith R.","family":"Horton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoel","family":"Smicun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica A.","family":"Hetherington","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phillip J.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"Fishman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.ygyno.2009.12.012_bib1","doi-asserted-by":"crossref","first-page":"225","DOI":"10.3322\/caac.20006","article-title":"Cancer statistics, 2009","volume":"59","author":"Jemal","year":"2009","journal-title":"CA Cancer J. Clin."},{"issue":"1","key":"10.1016\/j.ygyno.2009.12.012_bib2","first-page":"100","article-title":"Treatment of adenocarcinoma of the endometrium at Memorial-James Ewing Hospitals, 1949-1965","volume":"47","author":"Homesley","year":"1976","journal-title":"Obstet. Gynecol."},{"issue":"2","key":"10.1016\/j.ygyno.2009.12.012_bib3","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/0002-9378(83)91042-6","article-title":"Stage I endometrial adenocarcinoma: treatment results in 835 patients","volume":"146","author":"Lotocki","year":"1983","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"1","key":"10.1016\/j.ygyno.2009.12.012_bib4","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1002\/1097-0142(19910701)68:1<98::AID-CNCR2820680120>3.0.CO;2-R","article-title":"Undifferentiated carcinoma of the endometrium. A histopathologic and clinical study of 31 cases","volume":"68","author":"Abeler","year":"1991","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.ygyno.2009.12.012_bib5","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0090-8258(91)90086-K","article-title":"Relationship between surgical-pathological risk factors and outcome in clinical stage I and II carcinoma of the endometrium: a Gynecologic Oncology Group study","volume":"40","author":"Morrow","year":"1991","journal-title":"Gynecol. Oncol."},{"issue":"8","key":"10.1016\/j.ygyno.2009.12.012_bib6","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1038\/nrc865","article-title":"Dissemination and growth of cancer cells in metastatic sites","volume":"2","author":"Chambers","year":"2002","journal-title":"Nat. Rev., Cancer"},{"issue":"Pt 1","key":"10.1016\/j.ygyno.2009.12.012_bib7","first-page":"29","article-title":"Tumor-host interactions as prognostic factors in the histologic assessment of carcinomas","volume":"21","author":"Crissman","year":"1986","journal-title":"Pathol. Annu."},{"issue":"4","key":"10.1016\/j.ygyno.2009.12.012_bib8","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1007\/s00018-005-5296-8","article-title":"Metastasis: cell-autonomous mechanisms versus contributions by the tumor microenvironment","volume":"63","author":"Kopfstein","year":"2006","journal-title":"Cell. Mol. Life Sci."},{"issue":"4","key":"10.1016\/j.ygyno.2009.12.012_bib9","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1023\/A:1006662811948","article-title":"Lipid characteristics in metastatic cells","volume":"17","author":"Ruggieri","year":"1999","journal-title":"Clin. Exp. Metastasis"},{"issue":"5-6","key":"10.1016\/j.ygyno.2009.12.012_bib10","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1080\/10408360600778836","article-title":"The tumor microenvironment: key to early detection","volume":"43","author":"Ariztia","year":"2006","journal-title":"Crit. Rev. Clin. Lab. Sci."},{"issue":"8","key":"10.1016\/j.ygyno.2009.12.012_bib11","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1038\/nrc1143","article-title":"The emerging role of lysophosphatidic acid in cancer","volume":"3","author":"Mills","year":"2003","journal-title":"Nat. Rev., Cancer"},{"issue":"1-3","key":"10.1016\/j.ygyno.2009.12.012_bib12","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S1388-1981(02)00179-8","article-title":"Lysophosphatidic acid is a bioactive mediator in ovarian cancer","volume":"1582","author":"Fang","year":"2002","journal-title":"Biochim. Biophys. Acta"},{"issue":"2","key":"10.1016\/j.ygyno.2009.12.012_bib13","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1002\/1097-0215(200102)9999:9999<::AID-IJC1166>3.0.CO;2-D","article-title":"Lysophosphatidic acid, a novel lipid growth factor for human thyroid cells: over-expression of the high-affinity receptor edg4 in differentiated thyroid cancer","volume":"92","author":"Schulte","year":"2001","journal-title":"Int. J. Cancer"},{"issue":"6","key":"10.1016\/j.ygyno.2009.12.012_bib14","first-page":"2482","article-title":"Constitutive and lysophosphatidic acid (LPA)-induced LPA production: role of phospholipase D and phospholipase A2","volume":"6","author":"Eder","year":"2000","journal-title":"Clin. Cancer Res."},{"issue":"12","key":"10.1016\/j.ygyno.2009.12.012_bib15","first-page":"4308","article-title":"Overexpression of edg-2\/vzg-1 induces apoptosis and anoikis in ovarian cancer cells in a lysophosphatidic acid-independent manner","volume":"5","author":"Furui","year":"1999","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ygyno.2009.12.012_bib16","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/978-1-4615-4793-8_38","article-title":"A subfamily of G protein-coupled cellular receptors for lysophospholipids and lysosphingolipids","volume":"469","author":"Goetzl","year":"1999","journal-title":"Adv. Exp. Med. Biol."},{"issue":"11","key":"10.1016\/j.ygyno.2009.12.012_bib17","first-page":"3704","article-title":"Lysophosphatidic acid induces urokinase secretion by ovarian cancer cells","volume":"5","author":"Pustilnik","year":"1999","journal-title":"Clin. Cancer Res."},{"issue":"3","key":"10.1016\/j.ygyno.2009.12.012_bib18","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1016\/j.ygyno.2006.06.036","article-title":"S1P regulation of ovarian carcinoma invasiveness","volume":"103","author":"Smicun","year":"2006","journal-title":"Gynecol. Oncol."},{"issue":"28","key":"10.1016\/j.ygyno.2009.12.012_bib19","doi-asserted-by":"crossref","first-page":"25600","DOI":"10.1074\/jbc.M302648200","article-title":"Identification of p2y9\/GPR23 as a novel G protein-coupled receptor for lysophosphatidic acid, structurally distant from the Edg family","volume":"278","author":"Noguchi","year":"2003","journal-title":"J. Biol. Chem."},{"issue":"33","key":"10.1016\/j.ygyno.2009.12.012_bib20","doi-asserted-by":"crossref","first-page":"23589","DOI":"10.1074\/jbc.M603670200","article-title":"GPR92 as a new G12\/13- and Gq-coupled lysophosphatidic acid receptor that increases cAMP, LPA5","volume":"281","author":"Lee","year":"2006","journal-title":"J. Biol. Chem."},{"issue":"26","key":"10.1016\/j.ygyno.2009.12.012_bib21","doi-asserted-by":"crossref","first-page":"17731","DOI":"10.1074\/jbc.M808506200","article-title":"Identification and characterization of a novel lysophosphatidic acid receptor, p2y5\/LPA6","volume":"284","author":"Yanagida","year":"2009","journal-title":"J. Biol. Chem."},{"issue":"8","key":"10.1016\/j.ygyno.2009.12.012_bib22","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1001\/jama.280.8.719","article-title":"Lysophosphatidic acid as a potential biomarker for ovarian and other gynecologic cancers","volume":"280","author":"Xu","year":"1998","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.ygyno.2009.12.012_bib23","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s11745-999-332-5","article-title":"Abnormal serum lysophospholipids in multiple myeloma patients","volume":"34","author":"Sasagawa","year":"1999","journal-title":"Lipids"},{"issue":"6","key":"10.1016\/j.ygyno.2009.12.012_bib24","doi-asserted-by":"crossref","first-page":"809","DOI":"10.3177\/jnsv.44.809","article-title":"The significance of plasma lysophospholipids in patients with renal failure on hemodialysis","volume":"44","author":"Sasagawa","year":"1998","journal-title":"J. Nutr. Sci. Vitaminol. (Tokyo)"},{"issue":"1","key":"10.1016\/j.ygyno.2009.12.012_bib25","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.ygyno.2008.09.019","article-title":"LPA receptor 2 mediates LPA-induced endometrial cancer invasion","volume":"112","author":"Hope","year":"2009","journal-title":"Gynecol. Oncol."},{"issue":"5","key":"10.1016\/j.ygyno.2009.12.012_bib26","doi-asserted-by":"crossref","first-page":"2376","DOI":"10.1210\/jc.87.5.2376","article-title":"Induction of hepatocyte growth factor in stromal cells by tumor-derived basic fibroblast growth factor enhances growth and invasion of endometrial cancer","volume":"87","author":"Yoshida","year":"2002","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"2","key":"10.1016\/j.ygyno.2009.12.012_bib27","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.canlet.2005.05.042","article-title":"Matrilysin over-expression in MCF-7 cells enhances cellular invasiveness and pro-gelatinase activation","volume":"236","author":"Wang","year":"2006","journal-title":"Cancer Lett."},{"issue":"1","key":"10.1016\/j.ygyno.2009.12.012_bib28","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1002\/ijc.20697","article-title":"Matrilysin (MMP-7) promotes invasion of ovarian cancer cells by activation of progelatinase","volume":"114","author":"Wang","year":"2005","journal-title":"Int. J. Cancer"},{"issue":"3","key":"10.1016\/j.ygyno.2009.12.012_bib29","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.ygyno.2009.08.019","article-title":"VEGFR-2 silencing by small interference RNA (siRNA) suppresses LPA-induced epithelial ovarian cancer (EOC) invasion","volume":"115","author":"Wang","year":"2009","journal-title":"Gynecol. Oncol."},{"issue":"9","key":"10.1016\/j.ygyno.2009.12.012_bib30","doi-asserted-by":"crossref","first-page":"e45","DOI":"10.1093\/nar\/29.9.e45","article-title":"A new mathematical model for relative quantification in real-time RT-PCR","volume":"29","author":"Pfaffl","year":"2001","journal-title":"Nucleic Acids Res."},{"issue":"7","key":"10.1016\/j.ygyno.2009.12.012_bib31","first-page":"1635","article-title":"Ovarian carcinoma regulation of matrix metalloproteinase-2 and membrane type 1 matrix metalloproteinase through beta1 integrin","volume":"59","author":"Ellerbroek","year":"1999","journal-title":"Cancer Res."},{"issue":"Pt 3","key":"10.1016\/j.ygyno.2009.12.012_bib32","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1042\/bj3070867","article-title":"Specific binding of urinary-type plasminogen activator (u-PA) to vitronectin and its role in mediating u-PA-dependent adhesion of U937 cells","volume":"307","author":"Moser","year":"1995","journal-title":"Biochem. J."},{"issue":"2","key":"10.1016\/j.ygyno.2009.12.012_bib33","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1006\/gyno.1999.5353","article-title":"Hepatocyte growth factor (HGF) induces invasion of endometrial carcinoma cell lines in vitro","volume":"73","author":"Bae-Jump","year":"1999","journal-title":"Gynecol. Oncol."},{"issue":"7","key":"10.1016\/j.ygyno.2009.12.012_bib34","first-page":"3194","article-title":"Lysophosphatidic acid promotes matrix metalloproteinase (MMP) activation and MMP-dependent invasion in ovarian cancer cells","volume":"61","author":"Fishman","year":"2001","journal-title":"Cancer Res."},{"issue":"Pt 3","key":"10.1016\/j.ygyno.2009.12.012_bib35","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1042\/bj2910677","article-title":"The bioactive phospholipid lysophosphatidic acid is released from activated platelets","volume":"291","author":"Eichholtz","year":"1993","journal-title":"Biochem. J."},{"issue":"9","key":"10.1016\/j.ygyno.2009.12.012_bib36","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.bbalip.2008.04.011","article-title":"Lysophospholipid interactions with protein targets","volume":"1781","author":"Parrill","year":"2008","journal-title":"Biochim. Biophys. Acta"},{"issue":"6","key":"10.1016\/j.ygyno.2009.12.012_bib37","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1089\/scd.2004.13.685","article-title":"Lysophosphatidic acid induces clonal generation of mouse neurospheres via proliferation of Sca-1- and AC133-positive neural progenitors","volume":"13","author":"Svetlov","year":"2004","journal-title":"Stem Cells Dev."},{"issue":"7","key":"10.1016\/j.ygyno.2009.12.012_bib38","first-page":"1706","article-title":"Lysophosphatidic acid (LPA) enhances the metastatic potential of human colon carcinoma DLD1 cells through LPA1","volume":"63","author":"Shida","year":"2003","journal-title":"Cancer Res."},{"issue":"3","key":"10.1016\/j.ygyno.2009.12.012_bib39","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1016\/S0022-5347(05)65345-1","article-title":"Guanosine phosphate binding protein coupled receptors in prostate cancer: a review","volume":"167","author":"Raj","year":"2002","journal-title":"J. Urol."},{"issue":"1","key":"10.1016\/j.ygyno.2009.12.012_bib40","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1046\/j.1471-4159.1998.70010066.x","article-title":"Lysophosphatidic acid induces necrosis and apoptosis in hippocampal neurons","volume":"70","author":"Holtsberg","year":"1998","journal-title":"J. Neurochem."},{"issue":"6","key":"10.1016\/j.ygyno.2009.12.012_bib41","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1002\/(SICI)1097-4547(19980915)53:6<685::AID-JNR7>3.0.CO;2-1","article-title":"Lysophosphatidic acid and apoptosis of nerve growth factor-differentiated PC12 cells","volume":"53","author":"Holtsberg","year":"1998","journal-title":"J. Neurosci. Res."},{"issue":"5","key":"10.1016\/j.ygyno.2009.12.012_bib42","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1073\/pnas.91.5.1908","article-title":"Lysophosphatidic acid possesses dual action in cell proliferation","volume":"91","author":"Tigyi","year":"1994","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"10","key":"10.1016\/j.ygyno.2009.12.012_bib43","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1016\/j.cellsig.2006.01.009","article-title":"Vascular smooth muscle migration and proliferation in response to lysophosphatidic acid (LPA) is mediated by LPA receptors coupling to Gq","volume":"18","author":"Kim","year":"2006","journal-title":"Cell. Signal."},{"issue":"8","key":"10.1016\/j.ygyno.2009.12.012_bib44","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1002\/eji.200323711","article-title":"Lysophosphatidic acid induces human natural killer cell chemotaxis and intracellular calcium mobilization","volume":"33","author":"Jin","year":"2003","journal-title":"Eur. J. Immunol."},{"issue":"8","key":"10.1016\/j.ygyno.2009.12.012_bib45","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1111\/j.1432-1033.2004.04066.x","article-title":"Activation of p21-activated kinase 1 is required for lysophosphatidic acid-induced focal adhesion kinase phosphorylation and cell motility in human melanoma A2058 cells","volume":"271","author":"Jung","year":"2004","journal-title":"Eur. J. Biochem."},{"issue":"2","key":"10.1016\/j.ygyno.2009.12.012_bib46","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.yexcr.2004.08.008","article-title":"Dual mode regulation of migration by lysophosphatidic acid in human gastric cancer cells","volume":"301","author":"Shida","year":"2004","journal-title":"Exp. Cell Res."},{"issue":"8","key":"10.1016\/j.ygyno.2009.12.012_bib47","doi-asserted-by":"crossref","first-page":"6595","DOI":"10.1074\/jbc.M308133200","article-title":"Lysophosphatidic acid (LPA) in malignant ascites stimulates motility of human pancreatic cancer cells through LPA1","volume":"279","author":"Yamada","year":"2004","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.ygyno.2009.12.012_bib48","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.ygyno.2004.08.001","article-title":"Lysophosphatidic acid enhances epithelial ovarian carcinoma invasion through the increased expression of interleukin-8","volume":"95","author":"So","year":"2004","journal-title":"Gynecol. Oncol."},{"issue":"11","key":"10.1016\/j.ygyno.2009.12.012_bib49","doi-asserted-by":"crossref","first-page":"2062","DOI":"10.1183\/09031936.94.07112062","article-title":"The role of matrix metalloproteases and their inhibitors in tumour invasion, metastasis and angiogenesis","volume":"7","author":"Ray","year":"1994","journal-title":"Eur. Respir. J."},{"issue":"3","key":"10.1016\/j.ygyno.2009.12.012_bib50","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/j.cardiores.2005.12.002","article-title":"Structure and function of matrix metalloproteinases and TIMPs","volume":"69","author":"Nagase","year":"2006","journal-title":"Cardiovasc. Res."},{"issue":"3","key":"10.1016\/j.ygyno.2009.12.012_bib51","doi-asserted-by":"crossref","first-page":"203","DOI":"10.2174\/1568009053765799","article-title":"Matrix metalloproteinases as therapeutic targets in cancer","volume":"5","author":"Vihinen","year":"2005","journal-title":"Curr. Cancer Drug Targets"},{"issue":"16","key":"10.1016\/j.ygyno.2009.12.012_bib52","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1016\/S0959-8049(01)00235-0","article-title":"Ovarian carcinoma cells in serous effusions show altered MMP-2 and TIMP-2 mRNA levels","volume":"37","author":"Davidson","year":"2001","journal-title":"Eur. J. Cancer"},{"issue":"1","key":"10.1016\/j.ygyno.2009.12.012_bib53","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1006\/gyno.2001.6477","article-title":"Activated matrix metalloproteinase-2\u2014a potential marker of prognosis for epithelial ovarian cancer","volume":"84","author":"Wu","year":"2002","journal-title":"Gynecol. Oncol."},{"issue":"8","key":"10.1016\/j.ygyno.2009.12.012_bib54","first-page":"2396","article-title":"Increased expression of matrix metalloproteinases (MMP)-2, MMP-9, and the urokinase-type plasminogen activator is associated with progression from benign to advanced ovarian cancer","volume":"7","author":"Schmalfeldt","year":"2001","journal-title":"Clin. Cancer Res."},{"issue":"3","key":"10.1016\/j.ygyno.2009.12.012_bib55","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1006\/gyno.1999.5381","article-title":"MMP-2 and TIMP-2 expression correlates with poor prognosis in cervical carcinoma\u2014a clinicopathologic study using immunohistochemistry and mRNA in situ hybridization","volume":"73","author":"Davidson","year":"1999","journal-title":"Gynecol. Oncol."},{"issue":"2","key":"10.1016\/j.ygyno.2009.12.012_bib56","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1002\/(SICI)1096-9896(199910)189:2<161::AID-PATH406>3.0.CO;2-2","article-title":"Expression of MMP-2 and MMP-9, their inhibitors, and the activator MT1-MMP in primary breast carcinomas","volume":"189","author":"Jones","year":"1999","journal-title":"J. Pathol."},{"issue":"5751","key":"10.1016\/j.ygyno.2009.12.012_bib57","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/284067a0","article-title":"Metastatic potential correlates with enzymatic degradation of basement membrane collagen","volume":"284","author":"Liotta","year":"1980","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.ygyno.2009.12.012_bib58","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1111\/j.1525-1438.2006.00717.x","article-title":"Endometrial tumor invasiveness is related to metalloproteinase 2 and tissue inhibitor of metalloproteinase 2 expressions","volume":"16","author":"Graesslin","year":"2006","journal-title":"Int. J. Gynecol. Cancer"},{"issue":"3","key":"10.1016\/j.ygyno.2009.12.012_bib59","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.ygyno.2004.06.028","article-title":"Gelatinases A and B (MMP-2 and MMP-9) in endometrial cancer-MMP-9 correlates to the grade and the stage","volume":"94","author":"Aglund","year":"2004","journal-title":"Gynecol. Oncol."},{"issue":"1","key":"10.1016\/j.ygyno.2009.12.012_bib60","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1046\/j.1525-1438.2003.13033.x","article-title":"Effects of hepatocyte growth factor on the expression of matrix metalloproteinases and their tissue inhibitors during the endometrial cancer invasion in a three-dimensional coculture","volume":"13","author":"Park","year":"2003","journal-title":"Int. J. Gynecol. Cancer"},{"issue":"3","key":"10.1016\/j.ygyno.2009.12.012_bib61","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1006\/gyno.2001.6294","article-title":"Localization of matrix metalloproteinases on endometrial cancer cell invasion in vitro","volume":"82","author":"Park","year":"2001","journal-title":"Gynecol. Oncol."},{"issue":"5","key":"10.1016\/j.ygyno.2009.12.012_bib62","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1002\/cncr.10355","article-title":"Presence of active gelatinases in endometrial carcinoma and correlation of matrix metalloproteinase expression with increasing tumor grade and invasion","volume":"94","author":"Di Nezza","year":"2002","journal-title":"Cancer"},{"issue":"Pt 18","key":"10.1016\/j.ygyno.2009.12.012_bib63","doi-asserted-by":"crossref","first-page":"2789","DOI":"10.1242\/jcs.111.18.2789","article-title":"The activation of ProMMP-2 (gelatinase A) by HT1080 fibrosarcoma cells is promoted by culture on a fibronectin substrate and is concomitant with an increase in processing of MT1-MMP (MMP-14) to a 45\u00a0kDa form","volume":"111","author":"Stanton","year":"1998","journal-title":"J. Cell. Sci."},{"issue":"12","key":"10.1016\/j.ygyno.2009.12.012_bib64","doi-asserted-by":"crossref","first-page":"6691","DOI":"10.1074\/jbc.270.12.6691","article-title":"Matrix metalloproteinase 7 (matrilysin) from human rectal carcinoma cells. Activation of the precursor, interaction with other matrix metalloproteinases and enzymic properties","volume":"270","author":"Imai","year":"1995","journal-title":"J. Biol. Chem."},{"issue":"5","key":"10.1016\/j.ygyno.2009.12.012_bib65","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1002\/(SICI)1097-0215(19991022)84:5<470::AID-IJC4>3.0.CO;2-D","article-title":"Enhanced production and activation of matrix metalloproteinase-7 (matrilysin) in human endometrial carcinomas","volume":"84","author":"Ueno","year":"1999","journal-title":"Int. J. Cancer"},{"issue":"2-3","key":"10.1016\/j.ygyno.2009.12.012_bib66","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1023\/A:1023039230052","article-title":"MT1-MMP and MMP-7 in invasion and metastasis of human cancers","volume":"22","author":"Shiomi","year":"2003","journal-title":"Cancer Metastasis Rev."},{"issue":"11","key":"10.1016\/j.ygyno.2009.12.012_bib67","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1158\/1541-7786.MCR-06-0153","article-title":"Inhibition of matrilysin expression by antisense or RNA interference decreases lysophosphatidic acid-induced epithelial ovarian cancer invasion","volume":"4","author":"Wang","year":"2006","journal-title":"Mol. Cancer Res."},{"issue":"2","key":"10.1016\/j.ygyno.2009.12.012_bib68","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1002\/(SICI)1097-0215(19980417)79:2<187::AID-IJC15>3.0.CO;2-7","article-title":"Expression and tissue localization of matrix metalloproteinase 7 (matrilysin) in human gastric carcinomas. Implications for vessel invasion and metastasis","volume":"79","author":"Yamashita","year":"1998","journal-title":"Int. J. Cancer"}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825809010130?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825809010130?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,29]],"date-time":"2023-05-29T11:48:46Z","timestamp":1685360926000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825809010130"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,4]]},"references-count":68,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,4]]}},"alternative-id":["S0090825809010130"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2009.12.012","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2010,4]]}}}